Beranda › Miopati
Uji klinis Miopati yang merekrut di AS
20 studi untuk Miopati merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Durham, NC10 studi
- Chicago, IL6 studi
- New York City, NY6 studi
- Boston, MA6 studi
- Houston, TX5 studi
- Cedar Rapids, IA4 studi
- Miami, FL4 studi
- Phoenix, AZ3 studi
- Baltimore, MD3 studi
- Charlotte, NC3 studi
- Jacksonville, FL3 studi
- Los Angeles, CA3 studi
- Plantation, FL3 studi
- Dallas, TX3 studi
- Orange, CA3 studi
- Pittsburgh, PA3 studi
- Washington, DC3 studi
- Ann Arbor, MI3 studi
- Gainesville, FL3 studi
Berdasarkan negara bagian
- Alabama3 studi
- Arizona4 studi
- California11 studi
- Florida7 studi
- Georgia3 studi
- Illinois7 studi
- Iowa4 studi
- Kansas3 studi
- Maryland6 studi
- Massachusetts6 studi
- Michigan3 studi
- Minnesota4 studi
- New York7 studi
- North Carolina12 studi
- Pennsylvania4 studi
- Tennessee3 studi
- Texas7 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Environmental Risk Factors for the Anti-synthetase Syndrome
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01276470Adult and Juvenile Myositis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT00017914RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Menerima pesertaFase 2/3
Usia 6 hingga 75 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07103746Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07823101A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Menerima pesertaFase 1
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06916806A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05895786A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Menerima pesertaFase 1
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07085104FT839 in Autoimmune Diseases
Menerima pesertaFase 1/2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07800871A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Menerima pesertaFase 1
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT06925542Descartes-08 in Autoantibody Myositis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07391605A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Menerima pesertaFase 1/2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06991114A Study of AZD0120 in Autoimmune Diseases
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07295847A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT07115745A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Menerima pesertaFase 1
Usia 12 hingga 70 · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT06308978Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Apr 2026 · NCT07160205Muscle Health Measurements Using Electrical Impedance Myography
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 3 Apr 2026 · NCT07502989MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Menerima pesertaStudi observasional
Usia 7 ke atas · Semua jenis kelamin · Diperbarui 28 Jan 2026 · NCT07374107Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
Menerima pesertaFase awal 1
Usia 45 hingga 75 · Semua jenis kelamin · Diperbarui 16 Jan 2026 · NCT06479863Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.